Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.18 - $11.25 $6,760 - $422,516
37,557 Added 44.55%
121,853 $30,000
Q1 2022

May 13, 2022

SELL
$0.54 - $1.11 $98,574 - $202,624
-182,545 Reduced 68.41%
84,296 $57,000
Q4 2021

Feb 14, 2022

BUY
$1.01 - $2.03 $1,219 - $2,450
1,207 Added 0.45%
266,841 $269,000
Q3 2021

Nov 12, 2021

BUY
$1.97 - $2.67 $11,867 - $16,084
6,024 Added 2.32%
265,634 $523,000
Q2 2021

Aug 13, 2021

BUY
$2.15 - $2.99 $558,161 - $776,233
259,610 New
259,610 $688,000

About ThermoGenesis Holdings, Inc.


  • Ticker THMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,321,400
  • Description
  • ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally cl...
More about THMO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.